Product image of Natriumvalproat Seacross (Sodium Valproate) supplied by GNH India

Natriumvalproat Seacross

Active Ingredient:
Sodium Valproate
Origin:
EU

Natriumvalproat Seacross (Sodium Valproate)

Sodium Valproate, the active ingredient in Natriumvalproat Seacross, is an anticonvulsant presented as an injectable solution for intravenous use. It is employed to control generalized and focal seizures, to stabilize mood during manic episodes of bipolar disorder, and to prevent migraine attacks in patients for whom other therapies are unsuitable.

GNH India supplies Natriumvalproat Seacross as a licensed, Good Distribution Practice‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under stringent quality and regulatory standards, and ensuring timely delivery.

Manufacturer / TM Owner

Seacross Pharma (Europe) Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Sodium Valproate is an anticonvulsant that modulates neuronal excitability and is indicated for several neurological and psychiatric conditions.
  • Epilepsy (generalized and focal seizures): reduces seizure frequency and severity.
  • Bipolar disorder (manic episodes): stabilizes mood and prevents recurrence of mania.
  • Migraine prophylaxis: decreases the number of migraine attacks and associated disability.

How It Works

  • Sodium Valproate increases brain gamma‑aminobutyric acid (GABA) concentrations by inhibiting GABA transaminase and also blocks voltage‑gated sodium channels, leading to stabilization of neuronal membranes and reduced neuronal firing, which underlies its antiepileptic, mood‑stabilising, and migraine‑preventive effects.

Side Effects

Sodium Valproate may cause a range of adverse reactions.

Common Side Effects

  • Nausea or gastrointestinal upset
  • Tremor or unsteady movements
  • Weight gain or increased appetite
  • Drowsiness or fatigue
  • Hair loss or thinning
  • Mild rash or skin irritation

Serious or Rare Side Effects

  • Hepatotoxicity or severe liver injury
  • Pancreatitis, potentially life‑threatening
  • Severe skin reactions such as Stevens‑Johnson syndrome
  • Thrombocytopenia or significant drop in platelet count
  • Hyperammonemia leading to encephalopathy
  • Suicidal thoughts or behavior

Precautions & Warnings

  • When using Natriumvalproat Seacross, several safety considerations apply.
  • Pregnancy: contraindicated (Category X) due to high teratogenic risk.
  • Liver function: monitor hepatic enzymes regularly during therapy.
  • Blood counts: perform periodic platelet and complete blood count monitoring.
  • Drug interactions: review concomitant medications for major interaction potential.
  • Renal impairment: assess kidney function and adjust therapy if needed.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Sodium Valproate interacts with several medicines; careful management is required.

Major Interactions (Avoid)

  • Strong CYP450 inhibitors (e.g., ritonavir) – may raise valproate levels.
  • CYP450 inducers (e.g., carbamazepine, phenytoin) – may lower valproate concentrations.
  • Aspirin or other NSAIDs – increase risk of bleeding.
  • Lamotrigine – heightened risk of severe skin reactions.
  • Oral contraceptives – reduced contraceptive efficacy.

Moderate Interactions (Monitor Closely)

  • Acetaminophen – may elevate liver enzymes.
  • Warfarin – potential enhancement of anticoagulant effect.
  • Certain antibiotics (e.g., erythromycin) – may modestly increase valproate levels.

Frequently Asked Questions

Natriumvalproat Seacross contains sodium valproate and is indicated for the treatment of generalized and focal seizures in epilepsy, for the management of manic episodes in bipolar disorder, and for migraine prophylaxis in patients who need preventive therapy.

Sodium valproate raises brain GABA levels by inhibiting GABA transaminase and blocks voltage‑gated sodium channels, which together dampen excessive neuronal firing. This dual action underlies its effectiveness in controlling seizures, stabilising mood, and reducing migraine frequency.

The specific dose of Natriumvalproat Seacross is individualized and must be determined by a qualified prescriber based on the patient’s condition, age, weight, renal and hepatic function, and response to therapy.

Sodium valproate is classified as Pregnancy Category X because it carries a high risk of birth defects and developmental disorders. It is contraindicated during pregnancy and is not recommended for breastfeeding mothers.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Compared with agents such as carbamazepine or phenytoin, sodium valproate offers broader spectrum seizure control, including both generalized and focal seizures, and additional mood‑stabilising benefits. However, it has a higher risk of hepatic toxicity and teratogenicity, which may influence drug‑selection decisions.

The injectable solution should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use to maintain stability.

Natriumvalproat Seacross is supplied as an injectable solution for intravenous administration. It is typically infused over a period defined by the prescribing clinician, using aseptic technique and appropriate infusion equipment.

Serious risks include liver failure, pancreatitis, severe skin reactions such as Stevens‑Johnson syndrome, thrombocytopenia, hyperammonemia leading to encephalopathy, and increased suicidal thoughts. Prompt medical attention is required if any of these events occur.

Contraindications include pregnancy, known hypersensitivity to sodium valproate, severe hepatic impairment, and patients with mitochondrial disorders such as POLG‑related disease. Caution is also advised in individuals with significant renal dysfunction or a history of pancreatitis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sodium Valproate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT